ACTIVATED PROTEIN-C - ANTITHROMBOTIC PROPERTIES AND INFLUENCE ON FIBRINOLYSIS IN AN ANIMAL-MODEL

被引:10
作者
ROMISCH, J
DIEHL, KH
REINER, G
PAQUES, EP
机构
[1] J. Römisch, K-H. Diehl, G. Reiner, E-P. Pâques, Research Laboratories of Behringwerke AG, P.O. Box 11 40
关键词
ACTIVATED PROTEIN-C; THROMBOSIS MODEL; HALF-LIFE; ANTITHROMBOTIC EFFECT; PROFIBRINOLYTIC EFFECT;
D O I
10.1016/0268-9499(91)90023-W
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The in vivo antithrombotic and profibrinolytic properties of human plasma protein C were investigated in a metallic coil induced thrombus model in the rat. Protein C, purified immunoadsorption, was activated by thrombin and thereafter administered to the animals. Half-life of activated protein C (APC) revealed to be 15-16 min for the antigen, but only 7-8 min for the anticoagulant activity. Thrombus formation was reduced by APC in a dose-dependent statistically significant manner. A profibrinolytic effect of APC was observed when administered in combination with human tissue plasminogen activator. APC alone caused a reduction of thrombus weight. However, both effects were statistically not significant.
引用
收藏
页码:191 / 196
页数:6
相关论文
共 25 条
[1]  
BERNAT A, 1986, THROMB RES S, V6, P112
[2]   HUMAN PROTEIN C INDUCES ANTICOAGULATION AND INCREASED FIBRINOLYTIC-ACTIVITY IN THE CAT [J].
BURDICK, MD ;
SCHAUB, RG .
THROMBOSIS RESEARCH, 1987, 45 (04) :413-419
[3]   INFLUENCE OF PROTEIN-C ACTIVATION ON BLOOD-COAGULATION AND FIBRINOLYSIS IN SQUIRREL-MONKEYS [J].
COLUCCI, M ;
STASSEN, JM ;
COLLEN, D .
JOURNAL OF CLINICAL INVESTIGATION, 1984, 74 (01) :200-204
[4]   GENERATION OF FIBRINOLYTIC-ACTIVITY BY INFUSION OF ACTIVATED PROTEIN-C INTO DOGS [J].
COMP, PC ;
ESMON, CT .
JOURNAL OF CLINICAL INVESTIGATION, 1981, 68 (05) :1221-1228
[5]  
COMP PC, 1980, REGULATION COAGULATI, P583
[6]   DIVERSITY IN THE LIPOCORTIN CALPACTIN FAMILY [J].
CROMPTON, MR ;
MOSS, SE ;
CRUMPTON, MJ .
CELL, 1988, 55 (01) :1-3
[7]  
DEFOUW NJ, 1988, THROMB HAEMOSTASIS, V60, P328
[8]  
EMERICK SC, PHARM TOXIKOLOGY PRO, P351
[9]  
ESMON CT, 1989, J BIOL CHEM, V264, P4743
[10]  
ESMON CT, 1984, RES CLIN LAB, V14, P455